Peptide_Journey
Well-known member
2mg for maintenance with A1C in normal range, kidneys still improving, and cardiovascular benefits continuing is the full metabolic picture that makes the stop question hard to answer. The OP's doctor suggesting switching from metformin to Ozempic makes sense mechanically - the GLP-1 mechanism hits cardiovascular and kidney benefit pathways that metformin doesn't cover. What's the main hesitation about making the switch?